Pieter Rottiers
Chief Executive Officer at Intrexon ActoBiotics NV
Pieter Rottiers active positions
| Companies | Position | Start | End |
|---|---|---|---|
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 2013-10-08 | - | |
| Corporate Officer/Principal | 2009-08-20 | 2013-10-08 |
Career history of Pieter Rottiers
Former positions of Pieter Rottiers
| Companies | Position | Start | End |
|---|---|---|---|
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | 2005-12-31 | 2005-12-31 |
Training of Pieter Rottiers
| Ghent University | Doctorate Degree |
Statistics
International
| Belgium | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
- Stock Market
- Insiders
- Pieter Rottiers
- Experience
